3 Biotech Stocks on Our ASCO Watchlist

Wealth Daily submits: By Ian Cooper Even though the American Society of Clinical Oncology's (ASCO) super-influential conference may not kick off for another two months, it's best to start backing up the truck now. You see, this very conference is where biotech companies announce some of their clinical research data. Historically, we've see biotech stocks run up going into the conference.

By David Greene:The American Society of Clinical Oncology (ASCO) posted its list of abstracts to be presented at the influential Annual Meeting May 30- June 4 last week and investors have been busy going through the information. Why? It is an accepted fact that biopharmaceutical and medical device companies that have an abstract being presented on their new drug or promising medical device can experience nice returns in their stock during this time.

By StockPandit: << Return to Part 2

By Ohad Hammer:Below is a list of drugs and companies which will have meaningful data at this year's annual meeting of American Society of Clinical Oncology (ASCO). As I will be attending this year's conference, I will try to write updates on a regular basis. Feel free to send me questions or post them as comments to this post. PD1 antibodies - the next big thing in oncology

By Jessica King Holden:As many interested in the biotech sector are aware, the American Society of Clinical Oncology (ASCO) 2012 annual meeting will take place in Chicago, June 1-5.

By StockPandit: << Return to Part 3

By Andrew J. Norris: We are now at the start of the largest meeting in the world for Pharma and Biotech and the data released at this conference can have significant implications for biotech investors. The conference is the 2012 meeting of the American Society of Clinical Oncology (ASCO) being held from June 1 to June 5 in Chicago IL. Presenters will range from Genentech, Eli Lilly & Co.

Chemistfrog submits:Attracting more than 30,000 oncology professionals from around the world, the 47th annual meeting of the American Society of Clinical Oncology (ASCO) will meet this year from June 3-7th in Chicago, Illinois. Big pharmaceutical companies from $166 billion market cap Pfizer (NYSE: PFE) to $2.6 million market microcap biotech Genta Incorporated (OTC: